Drrx stock forecast.

In trading on Thursday, drugs shares were relative laggards, down on the day by about 0.1%. Helping drag down the group were shares of Durect (DRRX), down about 40.2% and shares of Pain ...Let’s talk about penny stocks. These are equities that trade for less than $5 per share, at the very bottom of the price range. While they are priced that low for a reason – and the reasons may vary – a low price in itself doesn’t mean that the stock’s fundamentals are sour. Smart investors can find some trueCUPERTINO, Calif., July 20, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment ...(See DRRX stock forecast) Ovid Therapeutics . Next up is Ovid Therapeutics, a biopharmaceutical company working to develop new medications for the treatment of rare neurological disorders, ...

Nov 6, 2023 · The Price and Consensus chart displays the company's stock price along with the consensus estimate. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The ... Oct 2, 2023 · Nevertheless, analysts rate DRRX a unanimous strong buy with a $29.80 target, implying 1,097% upside. On the date of publication, ... PayPal Stock Is a No-Gainer, Not a No-Brainer

Stock Price Forecast. The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 17.75, with a high estimate of 37.00 and a low estimate of 5.00. The median...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up to date on the world markets.

Get the latest Pieris Pharmaceuticals Inc (PIRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Past Earnings Growth Analysis. Earnings Trend: DRRX is unprofitable, and losses have increased over the past 5 years at a rate of 17.7% per year. Accelerating Growth: Unable to compare DRRX's earnings growth over the past year to its 5-year average as it is currently unprofitable. Earnings vs Industry: DRRX is unprofitable, making it difficult ...Find the latest DURECT Corporation (DRRX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stocks to buy today. However, you might be unsure how to begin.

On average, Wall Street analysts predict that Durect 's share price could reach $34.00 by Aug 10, 2024. The average Durect stock price prediction forecasts a potential upside …

Get the latest Galera Therapeutics Inc (GRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

For DURECT stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average DURECT stock forecast of $0.99, a high forecast of $1.6, and a low …View the latest DRRX earnings date, analysts forecasts, earnings history, ... What is DURECT's EPS forecast for next year? DURECT's earnings are expected to grow from ($1.46) per share to ($1.24) per share in the next year. ... Stock Ideas and Recommendations.Get the latest DURECT Corp (DRRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Nov 13, 2023 · Past Earnings Growth Analysis. Earnings Trend: DRRX is unprofitable, and losses have increased over the past 5 years at a rate of 17.7% per year. Accelerating Growth: Unable to compare DRRX's earnings growth over the past year to its 5-year average as it is currently unprofitable. Earnings vs Industry: DRRX is unprofitable, making it difficult ... Celebrations may be in order for DURECT Corporation ( NASDAQ:DRRX ) shareholders, with the analysts delivering a...

The Takeda Pharmaceutical 52-week low stock price is 13.19, which is 6.8% below the current share price. ... DURECT (DRRX), United States, $0.018B, 0.00. Jaguar ...NASDAQ Health Care/Life Sciences Compare to Open 0.627 Prior Close 0.62 (11/30/23) 1 Day DRRX 5.13% DJIA 0.82% Russell 2K 2.96% Health Care/Life Sciences 0.38% …If you’re looking for stocks under $10 to buy, you can do a lot worse than these highly-rated picks. BBAI BigBear.ai $4.05 APPH AppHarvest $0.95 DRRX Durect 5.18 AUVI Applied UV $1.13 ARDX ...DURECT (NASDAQ:DRRX) stock price plunges 31% as it entered into definitive agreements for the purchase and sale of an aggregate of 2.99M shares of common stock and warrants to purchase up to 2.99M ...Durect DRRX is set to give its latest quarterly ... New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).DSEY one year forecast. Diversey Holdings stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast DSEY stock forecast for 2023 – 2027. Last updated: November 17, 2023. Are you interested in Diversey Holdings, Ltd. stocks prediction?

Discover historical prices for DRRX stock on Yahoo Finance. View daily, weekly or monthly format back to when DURECT Corporation stock was issued.

CUPERTINO, Calif., July 20, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment ...Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Complete Durect Corp. stock information by Barron's. View real-time DRRX stock price and news, along with industry-best analysis. The average one-year price target for DRRX / Durect Corp is $6.885. The forecasts range from a low of $5.05 to a high of $8.925. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or ...Get the latest DURECT Corp (DRRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Durect Corp (DRRX) Stock Price Today, Quote, Latest Discussions, Interactive Chart and News Advertisement 3rd Party Ad. Not an offer or recommendation by Stocktwits. See …DRRX Stock 12 Months Forecast. $8.50. (1187.88% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Durect in the last 3 months. The average price target is $8.50 with a high forecast of $8.50 and a low forecast of $8.50. The average price target represents a 1187.88% change from the last price of $0.66.The Neurocrine Biosciences 52-week low stock price is 89.04, which is 23.6% below the current share price. ... DURECT (DRRX), United States, $0.019B, 0.00.DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment of acute organ injury and chronic liver diseases ...3 analysts have issued 12-month price objectives for Broadwind's stock. Their BWEN share price targets range from $6.00 to $9.00. On average, they predict the company's share price to reach $7.67 in the next twelve months. This suggests a possible upside of 250.1% from the stock's current price. View analysts price targets for BWEN or view top ...

Oct 19, 2023 · The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ...

Upside potential of 134% is at play.Overall, the bulls take the lead on this one. Out of 5 total reviews published in the last three months, all 5 analysts rated the stock a Buy. Therefore, the ...

Durect (DRRX) delivered earnings and revenue surprises of 13.21% and 2.79%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?Research DURECT's (Nasdaq:DRRX) stock key valuation metrics while comparing it with its industry peers & market side by side. Research DURECT's ... The above table shows the analyst DRRX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts ...(See DRRX stock forecast) Ovid Therapeutics . Next up is Ovid Therapeutics, a biopharmaceutical company working to develop new medications for the treatment of rare neurological disorders, ...Durect Corp (NASDAQ:DRRX) has a beta value of 1.29 and has seen 1.24 million shares traded in the last trading session. The company, currently valued at $14.51M, closed the last trade at $0.53 per share which meant it -0.87% during that session. The DRRX stock price is -1692.45% off its 52-week high ...7 Jun 2023 ... Bond & Stock Ratings · Conference Call Announcements · Contracts · Cryptocurrency · Dividends · Earnings · Earnings Forecasts & Projections ...Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. $233.0401 -1.2599 -0.54%. $190.76 +1.07. DURECT Corporation Common Stock ... The BigBear.ai Holdings stock price gained 1.72% on the last trading day (Wednesday, 22nd Nov 2023), rising from $1.74 to $1.77. During the last trading day the stock fluctuated 6.32% from a day low at $1.74 to a day high of $1.85. The price has risen in 8 of the last 10 days and is up by 18.79% over the past 2 weeks.Mar 24, 2023 · DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader.

Based on analysts offering 12 month price targets for DRRX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Nov 14, 2023 · Future criteria checks 2/6. DURECT is forecast to grow earnings and revenue by 16.9% and 47.9% per annum respectively while EPS is expected to grow by 19.9% per annum. SNBR Stock Outlook. Sleep Number updated its outlook for the full year of 2023 in its latest earnings report as well. It now expects diluted EPS to be up to -70 cents while revenue will decrease ...DRRX stock forecast Our latest prediction for Durect Corp's stock price was made on the May 26, 2020 when the stock price was at 2.66$. In the short term (2weeks), DRRX's stock price should outperform the market by 4.58%. During that period the price should oscillate between -11.17% and +17.56%.Instagram:https://instagram. what is a funded traderwhat is goldback currencywhat is the best online banking apprun stock forecast DURECT Stock Earnings. The value each DRRX share was expected to gain vs. the value that each DRRX share actually gained. DURECT ( DRRX) reported Q3 2023 earnings per share (EPS) of -$0.11, beating estimates of -$0.41 by 72.98%. In the same quarter last year, DURECT 's earnings per share (EPS) was -$0.11. DURECT is expected to release next ... 5 year treasuryiphone 15 release event Get the latest AcelRx Pharmaceuticals Inc (ACRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. mvst news Stock Price Forecast The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 34.50, with a high estimate of 44.00 and a low estimate of 32.00. The median estimate represents a +984.91% increase from the last price of 3.18.Nov 24, 2023 · Analyst Forecast According to 4 analysts, the average rating for DRRX stock is "Buy." The 12-month stock price forecast is $36.5, which is an increase of 5,430.30% from the latest price.